ARCHIVES

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

January 20, 1984

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010

Tri-Institutional Stem Cell Initiative Funds Grants.

August 4, 2006

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990